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(Cyclophosphamide Tablets and Injections，CTX)200mg/kg 剂量，0.2ml/10g 小鼠腹
腔注射，建立肝癌 H22荷瘤小鼠化疗后模型,旨在复制化疗药物产生毒副作用的模
型。随机分组为模型组、CTX 组(0.033g)，CHBD 高、中、低剂量组(117.00g, 58.50g, 





(Enzyme-linked immunosorbent assay, ELISA)检测小鼠肿瘤细胞相关凋亡因子检
测：小鼠 B 淋巴细胞瘤-2 基因(B-cell lymphoma-2, Bcl-2)相关 X 蛋白(Bcl-2 
assaciated X protein, BAX)、小鼠胱天蛋白酶 3(Cysteinyl aspartate specific 
proteinase, Casp-3)、Bcl-2、小鼠表皮生长因子受体 (Epidermal growth factor 
receptor, EGFR)的表达及检血细胞生成相关因子：脾组织促红细胞生成素
(Erythropoietin, EPO)、粒细胞-巨噬细胞集落刺激因子(Granulocyte-macrophage 




都有 1-2 只小鼠死亡，可能与实验操作、药物耐受等因素有关。CHBD 中药组小















CHBD 中药组整体抑瘤率不及 CTX 组，但 CHBD 高剂量组水平明显提高；CHBD
中药高、中剂量组的脾脏重量、脾脏指数高于模型组及 CTX 组(P<0.05 或
P<0.01)；光镜下 CHBD 中药组的瘤组织恶化程度较模型组明显减轻，细胞破坏
程度低于 CTX 组。 
2. CHBD 中药组 BAX(P<0.01)及促细胞凋亡的中药效应酶 Casp-3 的表达量
明显高于模型组(P<0.05 或 P<0.01)，而凋亡抑制基因 Bcl-2 的表达低于模型组、
CTX 组(P<0.05 或 P<0.01)；CHBD 低剂量组肿瘤组织恶性程度低于模型组，瘤
细胞凋亡高于模型组。CHBD 中药组 EGFR 表达明显低于模型组(P<0.05 或
P<0.01)、CTX 组(P<0.01)。与模型组(P<0.05 或 P<0.01)、CTX 组(P<0.05)比较，
CHBD 中药组 CyclinD1 蛋白含量明显降低，高剂量有极显著的统计学意义，低
剂量无统计学意义。 
3. 模型组和 CTX 组红细胞(RBC)、白细胞(WBC)、血小板(PLT)减少数量较
CHBD 中药组而明显(P<0.05 或 P<0.01)；CHBT 中药组高剂量各数值均明显高
于模型组、CTX 组，统计学意义极其显著(P<0.01)，中、低剂量组与模型组、CTX
组比较差异有显著统计学意义(P<0.05 或 P<0.01)。CHBD 中药组中 EPO 含量明
显高于模型组、CTX 组(P<0.05 或 P<0.01)，其中低剂量组与模型组、CTX 组比
较有明显差异性(P<0.05)，而高剂量组、中剂量组具有极显著的差异性(P<0.01)。
CHBD 中药组 GM-CSF 含量均较模型组、CTX 组高，都具有极其显著的差异性
(P<0.01)。 
结论：CHBD 中药组小鼠整体生存条件优于 CTX 组，对体重、免疫器官重
量方面的影响有积极的作用，CHBD 中药组小鼠机体能够维持平稳整体状态，能
够促进瘤组织凋亡基因BAX与Casp-3的表达，抑制瘤组织凋亡基因Bcl-2、EFGR
及瘤细胞增值相关蛋白 CyclinD1 蛋白的表达量，明确了 CHBD 有促肿瘤细胞凋
亡作用，促进细胞凋亡相关因子生成可能是其机制之一。一定浓度的 CHBD 能
促进化疗后 EPO 和 GM-CSF 的生成并增强活性，刺激血细胞的产生，维持外周
血象稳定性，可能是其改善癌症化疗后血细胞生成的机理之一。 



















Objective: This experiment is to study of Ciji Hua’ai Baosheng Decoction 
(CHBD) to improve the overall function of the body’s role in post-liver tumor 
chemotherapy. This research is to assess the effects of CHBD on protection of blood 
cells, generation of hematopoietic related factors, apoptosis correlation factors of liver 
tumor chemotherapy. This research will provide a scientific basis for CHBD in 
clinical application. 
Method: H22 hepatoma carcinoma cells were cultivated and diluted to 2×10
7
/ml. 
A total of 60 specific pathogen-free Kunming mice(KM) were inoculated into the 
right front armpit with H22 hepatoma cancer cells. Breeding conventional for 7 days, 
all mice had grown subcutaneous tumors and were carried out intraperitoneal injection 
of Cyclophosphamide Tablets and Injections (CTX, 200mg/kg) to establish the H22 
transplanted tumor mouse chemotherapy model designed to replicate the 
chemotherapy drugs with toxic effects, then they were randomly divided into 5 groups 
such as model, CTX control (0.033g/kg) and three CHBD (117g/kg, 58.5g/kg and 
29.25g/kg) groups with 12 mice in each group. They were administered next day after 
making model. Mice were given conventional feed and water. The model group was 
given intragastric administration of normal saline. The other group was treated with 
different drugs. Survival state was observed. After 10 days of continuous dosing, mice 
were sacrificed after fasting 24 hours and remove specimens. Mice were weighed and 
the transplanted tumors were stripped. Thymus and spleen were peeled off and 
measured the thymus and spleen indices. The postchemotherapy transplanted tumor 
inhibition ratios were counted. Pathological tissue structural change through HE 
staining was detected by light microscope, blood cells was gathered through pricking 
eyeball analyzed by blood analyzer. The protein level of serum Bcl-2 assaciated X 
protein(BAX), B-cell lymphoma-2(Bcl-2), Cysteinyl aspartate specific 
proteinase(Casp-3), Epidermal growth factor receptor(EGFR), Erythropoietin(EPO) 
and Granulocyte-macrophage colony stimulating factor(GM-CSF) was detected by 
enzyme-linked immunosorbent assay (ELISA), the protein expression of CyclinD1 in 
femur bone marrow was detected by immunohistochemisty. 
Results:  
1. After modeling the experimental mice in each group have different degrees of 















significantly reduced. Gloss hair and weight loss was significantly reduced in mice. 
CHBD groups were generally in good condition and a normal feeding, weight loss is 
not obvious. After modeling, tumor model group was significantly increased speed, 
while increasing tumor CHBD groups slower. Different groups had 1-2 mice died, 
probably as the experimental operation, drug tolerace and other factors. The spleen 
weight and spleen index in CHBD groups were higher than CTX group (P<0.05; 
P<0.01). The in three CHBD was distinctly decreased than the model and CTX 
groups (P<0.01). Under the light microscope, the deteriorated degree of tumor tissue 
and the proliferation degree of tumor cells in three CHBD groups were obviously 
milder than the model group.  
2. The protein content of the pro-apoptotic gene Bax and effective enzyme 
Caspase-3 in CHBD (58.5g/kg and 29.25g/kg) groups were distinctly higher than 
model groups (P<0.05; P<0.01). The protein content of the apoptosis inhibitory gene 
Bcl-2 in three CHBD was obviously decreased than that of the model and CTX 
groups (P<0.01). The protein level of serum EGFR in three CHBD groups was 
decreased, and lower than the model and CTX groups (P<0.05; P<0.01). The protein 
expression of CyclinD1 in femur bone marrow in CHBD (117g/kg and 58.5g/kg) 
groups was decreased obviously, which showed significant difference compared with 
model group (P<0.05; P<0.01). Effects of CHBD (117g/kg) on Bcl-2, Caspase-3, 
EGFR and CyclinD1 had more effective than effects of just single-use chemotherapy 
drug CTX (P<0.05; P<0.01).  
3. The number of red blood cells, white blood cells and platelets in CHBD 
groups were distinctly higher than the model and CTX groups(P<0.05; P<0.01). The 
level of blood cells in high does CHBD group was distinctly increased than the model 
and CTX groups (P<0.01). The content of EPO in was significantly higher than the 
model and CTX groups (P<0.05; P<0.01), while the high does and middle does 
CHBD groups were increased with a very significant difference (P<0.01). The 
content of GM-CSF in CHBD groups were increased, and higher than the model and 
CTX groups (P<0.01). 
Conclusion: In comparison, the overall living comdition in CHBD groups was 
better than the CTX group. The CHBD has a positive effect on body weight, organ 
weight and immunue aspect. A certain concentration of Ciji Hua’ai Baosheng 















restrain the expression of apoptosis inhibitory gene Bcl-2, and reduce the promotive 
effect of EGFR and CyclinD1 on tumor cell proliferation to play a synergetic role on 
promoting apoptosis of the chemotherapy model mice of transplanted tumor with H22 
hepatoma carcinoma cells, and parts of its possible mechanisms may be related with 
promoting tumor cell apoptosis and inhibiting proliferation. A certain concentration 
CHBD can promote the content of EPO and GM-CSF after chemotherapy. CHBD can 
stimulate blood cells production, maintaining the stability of peripheral blood. This 
may be one of the mechanisms to improve blood cells production after tumor 
chemotherapy. 
Keywords: Ciji Hua’ai Baosheng Decoction (CHBD); H22 hepatoma carcinoma cells; 
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第一章 前 言 
1. 概述 











































H22 荷瘤小鼠模型，以 CHBD 水煎剂给药，观察 CHBD 对肿瘤组织病理的改变，
给药期间观察整体生存状态；称量体重、瘤重、免疫器官重量，计算抑瘤率；计
算脾脏指数；检测外周血细胞；光镜下观察瘤组织病理结构改变；检测血清 Bcl-2























































我国治疗 HCC 的特色和优势，近年来复方中药制剂对 HCC 细胞的直接抑制，对
细胞凋亡的影响，以及在提高机体免疫力等方面的分子机制研究进展迅速； 复
方中药制剂预防和治疗 HCC 的临床疗效观察研究也取得了一定的进展。 
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